Immune Support, Adaptogen, and Longevity Herb

How astragalus (Huang Qi) boosts immune function, activates telomerase to slow cellular aging, and protects the cardiovascular system — with evidence from clinical trials, systematic reviews, and mechanistic research

Astragalus (Astragalus membranaceus, also called Huang Qi in traditional Chinese medicine) is one of the most thoroughly researched herbs in the world, with a 2,000-year history as a foundational immune tonic. Modern science has confirmed and expanded on that reputation: it modulates the immune system, helps the body adapt to stress, and contains compounds that activate telomerase — the enzyme that maintains the protective caps on your chromosomes. [1] In a randomized, double-blind, placebo-controlled trial published in 2024, a middle-aged group taking an astragalus-based supplement showed significantly longer telomeres after six months, while the placebo group showed no change. [3] It is also one of the few herbal medicines shown to restore immune balance in clinical populations — not simply stimulating immunity, but helping it calibrate correctly. [2]

How Astragalus Works

Astragalus root contains nearly 400 identified bioactive compounds. The most studied fall into three main families: astragalus polysaccharides (APS), astragalosides (particularly astragaloside IV), and flavonoids (notably calycosin and formononetin). Each class has distinct but overlapping biological actions.

Immune Modulation: Restoring Balance, Not Just Boosting

The dominant immune action of astragalus polysaccharides is immunomodulation — a more nuanced effect than simple immune stimulation. Rather than broadly activating the immune system (which can backfire in autoimmune conditions or cause excessive inflammation), APS helps shift the immune response toward an appropriate balance.

In healthy and immunocompromised individuals, astragalus:

Increases natural killer (NK) cell activity, which represents the body's first line of defense against viruses and abnormal cells
Enhances macrophage phagocytosis — the ability to engulf and destroy pathogens
Promotes T-helper cell (CD4+) activity while maintaining CD4/CD8 ratios within a healthy range
Stimulates antibody production by supporting B-cell function [5]

A clinical study of patients with herpes simplex keratitis — a condition involving immune dysregulation — found that astragalus treatment significantly shifted cytokine profiles toward a more balanced Th1/Th2 response, with improvements in gamma-interferon and IL-2 levels, while ribavirin (the pharmaceutical comparison) showed no immune-parameter changes. [2]

Telomerase Activation: Cellular Longevity

Among the most striking properties of astragalus is that its saponin compounds — particularly astragaloside IV and its metabolite cycloastragenol — are potent activators of telomerase, the enzyme responsible for maintaining telomere length.

Telomeres are the protective caps on the ends of chromosomes. They shorten with each cell division, and when they become critically short, cells enter a senescent state — no longer able to divide, contributing to aging and age-related disease. Telomerase counteracts this by rebuilding telomere length, and it is normally only active in stem cells and certain immune cells.

Cycloastragenol can reactivate telomerase in somatic cells, effectively counteracting the molecular clock of cellular aging. The 2024 randomized trial (n=40, 6 months) found that participants taking an astragalus-based supplement showed:

Significantly increased median telomere length
A lower percentage of critically short telomeres
No change in the placebo group over the same period [3]

This is consistent with earlier mechanistic studies confirming that cycloastragenol activates telomerase in multiple cell types. The clinical implications remain an active area of research, but the direction of evidence is consistent.

Cardiovascular Protection

Astragaloside IV has a second major area of well-documented benefit: the heart and vascular system. It protects myocardial cells through multiple pathways:

Antioxidant defense: reduces reactive oxygen species in cardiac tissue, protecting against oxidative damage following ischemia or stress
Anti-inflammatory action: inhibits NF-κB and downstream inflammatory cytokines in the myocardium
Anti-fibrotic effects: reduces pathological collagen deposition (fibrosis) that stiffens heart tissue after injury
Calcium homeostasis: helps regulate intracellular calcium, preventing the overload that leads to cell death in cardiac events
Autophagy regulation: promotes beneficial cellular cleanup processes in heart muscle cells [4]

Meta-analyses of trials in heart failure patients show that adding astragalus to conventional treatment improved left ventricular ejection fraction and reduced cardiac remodeling compared to conventional treatment alone.

Dosage and Forms

Traditional use and modern research have used widely varying preparations. For general guidance:

Dried root / decoctions: 9–30 g of dried root per day in traditional TCM formulas — this is the historical standard
Standardized extracts: 500–1,500 mg/day of dried root equivalent, often standardized to astragaloside IV content
Polysaccharide-standardized supplements: most immune-focused formulas are standardized to 40–70% polysaccharide content
Cycloastragenol for telomere support: studies typically use 5–25 mg/day of purified cycloastragenol or equivalent astragaloside IV doses

Astragalus is generally well tolerated. It is not known to be toxic at therapeutic doses, and adverse events in clinical trials are rare and mild. It is sometimes avoided by people on immunosuppressant medications due to its immune-activating properties. Caution is warranted during pregnancy as high-dose use has not been studied.

When to Use It

Astragalus is a good fit for:

Frequent colds or respiratory infections — immune tonic used seasonally or long-term
Recovery from illness or medical treatment — particularly supporting immune restoration after chemotherapy, where clinical evidence exists for maintaining white blood cell and platelet counts [5]
Cardiovascular support — especially as part of a broader heart-protective protocol
Longevity and anti-aging strategies — primarily for its telomere-related properties

It is not a fast-acting herb. Unlike echinacea (best taken acutely for a few days at illness onset), astragalus is traditionally used consistently over weeks to months as a tonic — building immune resilience over time rather than providing immediate acute relief.

See our Echinacea page for a complementary short-term immune herb, our Jiaogulan page for another TCM longevity adaptogen, and our Telomeres page for broader context on cellular aging.

Evidence Review

Auyeung, Han & Ko 2016 — Comprehensive Review

The Auyeung et al. review [1] in the American Journal of Chinese Medicine provides the most comprehensive synthesis of mechanistic and clinical evidence for astragalus. The review analyzed decades of research on astragalus polysaccharides, saponins, and flavonoids, with a focus on anti-inflammatory and cancer-protective mechanisms.

Key findings from the mechanistic literature:

APS activates dendritic cells, NK cells, T lymphocytes, and macrophages in a dose-dependent manner
Astragaloside IV inhibits NF-κB-driven inflammatory signaling, reducing TNF-α, IL-1β, IL-6, and other pro-inflammatory cytokines
Calycosin and formononetin (astragalus flavonoids) demonstrated selective cytotoxic effects in cancer cell lines and anti-angiogenic activity, potentially limiting tumor blood supply
In gastrointestinal protection studies, astragalus extracts reduced inflammation-associated cancer progression in model systems

The review notes that while mechanistic evidence is strong and consistent, most human clinical trials use astragalus as part of combination formulas in traditional Chinese medicine contexts, making it difficult to isolate dose-response relationships for specific outcomes from single-herb use.

Mao, Cheng & Zhou 2004 — Clinical Immunomodulation

This clinical trial [2] enrolled 106 patients with herpes simplex keratitis (HSK) — a condition where excessive immune activation damages the cornea — and compared astragalus treatment to ribavirin (an antiviral drug), with follow-up immune marker assessment.

Results in the astragalus group post-treatment:

Gamma-interferon (IFN-γ) significantly increased, indicating improved Th1 immune activity
IL-2 levels rose, supporting T-cell activation and adaptive immune response
IL-4 and IL-10 levels normalized (these Th2-dominant cytokines were elevated at baseline due to the disease state)
The CD4/CD8 ratio improved toward healthy norms
No significant changes in any parameter in the ribavirin group

The clinical importance here is not that astragalus stimulated immunity in a healthy person, but that it rebalanced a dysregulated immune response — reducing pathological Th2 dominance while restoring Th1 competence. This immunomodulatory, rather than simply immunostimulatory, profile is characteristic of astragalus and explains why it is used in both immunodeficient and autoimmune-adjacent conditions in traditional medicine.

de Jaeger et al. 2024 — Randomized Controlled Trial on Telomere Length

Published in Nutrients, this double-blind, placebo-controlled RCT [3] is the most rigorous clinical test of astragalus's telomere-lengthening effects to date.

Design:

n=40 healthy middle-aged volunteers
Duration: 6 months
Intervention: astragalus-based nutritional supplement vs. matched placebo
Primary outcomes: median telomere length, short telomere percentage, measured by quantitative PCR and flow-FISH

Results at 6 months:

Median telomere length significantly increased in the supplement group (p < 0.05); no change in placebo
Percentage of short telomeres significantly decreased in the supplement group; no change in placebo
Telomerase activity biomarkers were higher in the supplement group
No adverse events attributed to the supplement

This is a well-designed trial with clean endpoints. It confirms in a human randomized setting what had previously been established in cell culture: astragaloside IV and cycloastragenol can activate telomerase and measurably slow telomere attrition in middle-aged people. The 6-month duration is relatively short in the context of lifespan; longer follow-up trials would be needed to determine whether telomere-length gains translate to reduced age-related disease.

Yang et al. 2023 — Astragaloside IV and Cardiovascular Disease

This comprehensive review in Frontiers in Pharmacology [4] synthesized the evidence for astragaloside IV as a cardioprotective compound across nine major mechanisms.

The review catalogued protective effects at the molecular and cellular level across experimental models of myocardial ischemia, heart failure, hypertension, and arrhythmia:

Antioxidant protection: astragaloside IV increased superoxide dismutase (SOD) activity and reduced malondialdehyde (MDA, a lipid peroxidation marker) by 30–50% in ischemia-reperfusion models
Anti-apoptotic effects: reduced cardiomyocyte death by suppressing caspase-3 activation and Bcl-2/Bax ratio changes
Anti-fibrotic action: inhibited TGF-β1 signaling, the primary driver of pathological cardiac fibrosis
Anti-hypertrophic effects: reduced cardiomyocyte hypertrophy driven by pressure overload through modulation of calcineurin-NFAT signaling
Improved cardiac microcirculation: stimulated NO production in endothelial cells, supporting vasodilation and blood flow

The authors note that multiple small-to-moderate clinical trials combining astragalus with conventional treatment in heart failure consistently show additive benefits over conventional treatment alone — particularly in improving ejection fraction and reducing cardiac remodeling markers. A meta-analysis of these trials confirmed the benefit, though most included trials were conducted in China and had moderate methodological quality.

Li et al. 2020 — Immunopotentiation and Cancer Support

The Li et al. review [5] in the Journal of Ethnopharmacology synthesized evidence for astragalus as both a direct anti-tumor agent and an adjunct to cancer therapy, focusing specifically on its immunopotentiating (immune-restoring) properties.

Clinical evidence reviewed included a series of trials adding astragalus injections to chemotherapy in cancer patients:

In patients receiving chemotherapy, astragalus supplementation significantly reduced the decline in peripheral WBC and platelet counts — markers of bone marrow suppression from chemo toxicity
The CD4/CD8 ratio, typically disrupted by chemotherapy, was maintained at healthier levels in the astragalus groups
Immunoglobulin levels (IgG and IgM) were better preserved in astragalus-treated patients
Patients with astragalus supplementation reported lower rates of fatigue and nausea compared to chemotherapy-alone controls

The proposed mechanism: astragalus polysaccharides promote hematopoietic stem cell differentiation and protect bone marrow from cytotoxic damage, allowing faster immune and blood cell recovery. This specific application — immune restoration in the context of chemotherapy — has the strongest clinical evidence base for astragalus in a mainstream medical context.

Evidence Strength Summary

Immune function: Strong — multiple clinical trials and consistent mechanistic data confirm immunomodulatory effects; the clinical profile is immunoregulatory (balancing) rather than simply stimulating. Confidence: high.

Telomere lengthening: Moderate to high — clear mechanistic evidence, confirmed in a randomized controlled trial; long-term clinical significance is still being established. Confidence: moderate-to-high.

Cardiovascular protection: Moderate — strong mechanistic and animal data, consistent clinical signal in adjunct heart failure trials; needs larger high-quality RCTs. Confidence: moderate.

Cancer adjunct / chemotherapy support: Moderate — consistent clinical data for immune protection during chemotherapy, but most trials are from one geographic and institutional context. Confidence: moderate.

Overall, astragalus has one of the strongest evidence profiles among traditional Chinese herbs, with multiple mechanisms robustly confirmed and clinical benefits demonstrated across multiple domains.

References

Astragalus membranaceus: A Review of its Protection Against Inflammation and Gastrointestinal CancersAuyeung KK, Han QB, Ko JK. American Journal of Chinese Medicine, 2016. PubMed 26916911 →
Modulatory effect of Astragalus membranaceus on Th1/Th2 cytokine in patients with herpes simplex keratitisMao SP, Cheng KL, Zhou YF. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2004. PubMed 15015443 →
A Natural Astragalus-Based Nutritional Supplement Lengthens Telomeres in a Middle-Aged Population: A Randomized, Double-Blind, Placebo-Controlled Studyde Jaeger C, Kruiskamp S, Voronska E, Lamberti C, Baramki H, Beaudeux JL, Cherin P. Nutrients, 2024. PubMed 39275278 →
Review on the protective mechanism of astragaloside IV against cardiovascular diseasesYang C, Pan Q, Ji K, Tian Z, Zhou H, Li S, Luo C, Li J. Frontiers in Pharmacology, 2023. PubMed 37251311 →
Anti-tumor effects and mechanisms of Astragalus membranaceus (AM) and its specific immunopotentiation: Status and prospectLi S, Sun Y, Huang J, Wang B, Gong Y, Fang Y, Liu Y, Wang S, Guo Y, Wang H, Xu Z, Guo Y. Journal of Ethnopharmacology, 2020. PubMed 32243990 →